Recent 8-K filings for NNDM

• August 18, 2026, 8:00 AM ET other material materiality 0.40 neutral item 5.02item 7.01 ◈ executive_change

  Nano Dimension adds Nadav Kidron to board; Infinite Epigenetics exclusivity lapses without deal

  Nadav Kidron appointed to Nano Dimension board as Class II independent director, effective Aug 16, 2026; joins Audit and Compensation committees.

• August 6, 2026, 4:05 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Nano Dimension Q2 revenue up 12% to $29M; sells MarkForged to Stratasys

  Revenue $29.0M (+12.1% YoY); gross margin 45.9% vs 27.3% YoY.

• July 21, 2026, 4:56 PM ET leadership materiality 0.75 neutral item 1.01item 5.01item 5.02item 5.07item 8.01item 9.01 ◈ executive_change ×7

  Nano Dimension settles activist dispute; CEO Stehlin and three other directors resign, three new directors appointed

  Settlement with Murchinson cancels July 31 EGM; four directors resign including CEO David Stehlin.

• July 21, 2026, 4:05 PM ET other material materiality 0.65 positive item 8.01item 9.01

  Nano Dimension terminates HQ lease, expects $25M net cash savings through 2031

  Agreement to terminate corporate headquarters lease effective Dec 31, 2026; lease originally from MarkForged (2021) expiring 2031.

• June 17, 2026, 4:05 PM ET M&A materiality 0.80 positive item 7.01item 9.01

  Nano Dimension provides update on proposed Infinite Epigenetics acquisition, values company at net cash plus 20% premium

  Infinite Epigenetics is a commercial diagnostics platform with CLIA-certified lab, >120K samples, and >7,500 healthcare providers.

• June 15, 2026, 7:48 AM ET M&A materiality 0.85 neutral item 7.01item 9.01

  Nano Dimension signs non-binding term sheet to acquire Infinite Epigenetics for $890M stock consideration

  Infinite valued at $890M; Nano valuation based on net cash plus 20% premium plus ~$20M for Essemtec.

• June 11, 2026, 4:20 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  Nano Dimension faces activist-led EGM; board backs only two of six proposals

  Activist group (Murchinson, Nomis Bay, BPY, Boothbay funds, Oramed) demands EGM on July 31, 2026 in Waltham, MA.

• May 27, 2026, 6:30 AM ET M&A materiality 0.75 positive item 8.01item 9.01

  Nano Dimension sells MarkForged to Stratasys for $42.5M cash, reduces annual burn by $15M

  Nano Dimension sells MarkForged subsidiary to Stratasys (SSYS) for $42.5M in cash.

• May 26, 2026, 8:12 AM ET other material materiality 0.70 negative item 7.01item 9.01

  Nano Dimension board rejects Murchinson’s bid to replace three directors; strategic review continues

  Murchinson filed an amended Schedule 13D, seeking to replace three of five directors, including two it previously nominated and the CEO.

• May 7, 2026, 7:59 PM ET earnings materiality 0.85 negative item 2.02item 9.01 ◈ Earnings Releases

  Nano Dimension Q1 net loss $69.7M (incl. $40.4M impairment); revenue up 106% to $29.7M

  Revenue $29.7M (+106% YoY); adjusted gross margin 45.9% vs. 43.3%.

• April 30, 2026, 7:59 PM ET other material materiality 0.40 neutral item 8.01

  Nano Dimension updates on strategic review; sold AME and Fabrica lines on April 6

  Guggenheim and Houlihan Lokey engaged to evaluate monetization of product lines and financial resources.

• April 6, 2026, 7:59 PM ET M&A materiality 0.70 positive item 8.01item 9.01

  Nano Dimension sells AME & Fabrica product lines to Inspira for up to $12.5M

  Total consideration up to $12.5M: $2.0M cash upfront, up to $10.5M deferred based on 12-month performance.

• March 31, 2026, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01 ◈ Earnings Releases ×2

  Nano Dimension Q4 revenue up 142% to $35.3M; strategic review on track for Q2 2026

  Full-year 2025 revenue $102.4M (+77.3% YoY); Q4 revenue $35.3M (+142.4% YoY).

• February 3, 2026, 6:59 PM ET other material materiality 0.55 neutral item 1.01item 3.03item 8.01item 9.01 ◈ Material Agreements

  Nano Dimension adopts limited-duration rights plan with 9.99% trigger, expires Feb 2027

  Rights plan triggers if any person acquires 9.99%+ of ordinary shares without board approval.

• January 21, 2026, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Nano Dimension Q4 2025 preliminary revenue $35.0-35.5M, above guidance of $31.5-33.5M

  Q4 2025 preliminary revenue $35.0-35.5M, exceeding prior guidance of $31.5-33.5M; strength in defense, aerospace, automotive.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.70 · Most common event other_material

6 positive 2 negative 7 neutral

source · NNDM on sec.gov